A Practical Guide for Cardiologists to the Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease
Patients with type 2 diabetes are at increased cardiovascular risk. Until recently, reductions in HbA1c and the use of specific glucose-lowering agents have not had a clear, reproducible benefit in reducing the incidence of cardiovascular disease. However, over the past 5 years, members of two categ...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Radcliffe Medical Media
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/5a91fa8d33ae45ea8b5afd48cb104e34 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|